A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2002
11/20/2002	CN1380073A Ointment with functions of detoxification, relieving inflammation and stopping pain
11/20/2002	CN1380062A Saline medicine containing active adjuvant and complex medicine
11/20/2002	CN1380060A Solution type spray of antimycotic medicine for external application and its preparation method
11/20/2002	CN1094361C Composition comprising propolis and essential oil
11/20/2002	CN1094353C Pharmaceutical formulations containing beta-lactamasa inhibiting penem in combination with beta-lactam antibiotic and their use in treatment of bacterial infections
11/19/2002	US6482939 Form vi 5,6-dichloro-2-(isopropylamino)-1-(β-l-ribofuranosyl)-1h-bezimimidazole
11/19/2002	US6482924 Leptospira vaccine antigens for the prevention of Leptospirosis
11/19/2002	US6482920 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
11/19/2002	US6482848 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/19/2002	US6482845 Method for inhibiting interleukin-2 production using tricyclo compounds
11/19/2002	US6482843 Compounds and methods for use thereof in the treatment of cancer or viral infections
11/19/2002	US6482830 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
11/19/2002	US6482822 N-(iminomethyl)amines derivatives, their preparation, their use as medicines and compositions containing them
11/19/2002	US6482818 C-2 S/O-and S/N formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and β-lactamase inhibitors
11/19/2002	US6482801 Therapy for bacterial or protozoa infections
11/19/2002	US6482618 Self-enhancing, pharmacologically controllable expression systems
11/19/2002	US6482414 Cold-adapted equine influenza viruses
11/19/2002	US6482405 Antitumor
11/19/2002	US6482396 Combination of lactoferrin (lf) and glycomacropeptide (gmp) that exerts an antimicrobial effect in oral cavities
11/19/2002	CA2332631C Soft gelatin capsule manufacture
11/19/2002	CA2066134C Complexes of polyadenylic acid with polyuridylic acid
11/18/2002	CA2381637A1 Compositions and methods for treating or preventing convulsions or seizures
11/16/2002	CA2383556A1 High-efficiency assay for protein mannosyl transferases
11/14/2002	WO2002090600A2 A method for regulating immune function in primates using the foxp3 protein
11/14/2002	WO2002090558A1 Novel expression vectors and uses thereof
11/14/2002	WO2002090553A2 Recombinant fusion proteins and the trimers thereof
11/14/2002	WO2002090548A1 Method of purifying chromosomal dna replication initiating protein dnaa of pathogenic bacterium using affinity of dnaa protein for atp, method of evaluating antibacterial activity and method of screening compound having antibacterial activity using affinity of dnaa protein for atp
11/14/2002	WO2002090530A2 Kinases and phosphatases
11/14/2002	WO2002090524A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002	WO2002090504A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	WO2002090503A2 Anti-microbial peptides and compositions
11/14/2002	WO2002090382A2 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
11/14/2002	WO2002090364A1 Cephem compounds
11/14/2002	WO2002090363A1 ANHYDROUS CRYSTAL OF ss-LACTAM COMPOUND AND METHOD FOR PREPARATION THEREOF
11/14/2002	WO2002090361A1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/14/2002	WO2002090354A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides
11/14/2002	WO2002090353A1 Sulfonamides
11/14/2002	WO2002090352A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
11/14/2002	WO2002090350A1 Novel azole or triazole derivatives, method for preparing same and use thereof as antifungal medicines
11/14/2002	WO2002090348A1 Sulfonamides
11/14/2002	WO2002090337A1 Sulfonamides
11/14/2002	WO2002090332A2 Novel aeylheteroalkylaminε derivatives
11/14/2002	WO2002090326A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
11/14/2002	WO2002090025A1 Mathod for preparing micro powder containing anti-agglomerated nanometer silver, micro powder produced by the mathod and its application
11/14/2002	WO2002089850A1 Long acting antimicrobic preparation
11/14/2002	WO2002089845A1 Remedies for sepsis
11/14/2002	WO2002089838A1 Saponin inactivated mycoplasma vaccine
11/14/2002	WO2002089835A2 Pharmaceutical dosage form of amorphous nelfinavir mesylate
11/14/2002	WO2002089834A1 Bont/e or snap-25e for treating botulinum toxin a or c1 poisoning and inhibiting muscle contraction
11/14/2002	WO2002089832A2 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
11/14/2002	WO2002089821A1 Ophthalmic liquid preparation and liquid preparation for contact lens
11/14/2002	WO2002089817A2 Anti-virus agent
11/14/2002	WO2002089795A1 Method for treatment of tumors using nordihydroguaiaretic acid derivatives
11/14/2002	WO2002089792A1 Sulfonamides
11/14/2002	WO2002089785A1 Sulfonamides
11/14/2002	WO2002089780A2 Antiviral compounds
11/14/2002	WO2002089749A2 Arylsulfonamide ethers, and methods of use thereof
11/14/2002	WO2002089743A2 Use of compositions for treating rosacea
11/14/2002	WO2002089740A2 Sulfonamides
11/14/2002	WO2002089738A2 Proteomimetic compounds and methods
11/14/2002	WO2002089581A1 Antimicrobial compounds and methods for their use
11/14/2002	WO2002076476A3 Prodrugs of anticancer agents employing substituted aromatic acids
11/14/2002	WO2002072126A3 Invention relating to hcv diseases
11/14/2002	WO2002064616A3 Agonists and antagonists of sphingosine-1-phosphate receptors
11/14/2002	WO2002062392A3 Water-soluble compositions of bioactive lipophilic compounds
11/14/2002	WO2002051419A3 A pharmaceutical composition containing benzopyrano-oxopyrimidotetrahydrothiazine and its use in the treatment of hiv
11/14/2002	WO2002051233A3 Universal antimicrobial treatment
11/14/2002	WO2002024650B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/14/2002	WO2002018623A3 Methods and reagents for protease inhibition
11/14/2002	WO2002018404A3 Nucleoside derivatives for the treatment of hepatitis c
11/14/2002	WO2002016440A8 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections
11/14/2002	WO2002015661A8 Inhibitors of hiv replication and method of treatment of hiv infections
11/14/2002	WO2002009746A8 Vaccines comprising outer membrane vesciles from gram negative bacteria
11/14/2002	WO2001007030A3 Compositions an inhibitor of an accrab-like efflux pump for reducung microbial resistance to drugs
11/14/2002	US20020169439 Modular infusion device and method
11/14/2002	US20020169291 Interleukin-18 mutants, their production and use
11/14/2002	US20020169202 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same
11/14/2002	US20020169191 Oxazolidinone compounds and methods of preparation and use thereof
11/14/2002	US20020169177 Imidazole and benzimidazole caspase inhibitors and uses thereof
11/14/2002	US20020169164 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
11/14/2002	US20020169159 An acetamide derivative is useful for treatment of inflammatory and immune conditions and diseases; modulates the expressin and/or function of a chemokine receptor
11/14/2002	US20020169150 Hormone replacement therapy
11/14/2002	US20020169149 Antimicrobial formulations
11/14/2002	US20020169140 Minimising dosage required of chemotherapeutic agents for their use in antiviral, antibacterial, antiparasitic and anticancer chemotherapy; for treating neoplasms and tumours, viral, bacterial, or parasite infections
11/14/2002	US20020169131 TGF-alpha polypeptides, functional fragments and methods of use therefor
11/14/2002	US20020169114 Formulation of boronic acid compounds
11/14/2002	US20020169105 Use of active enamel substances as wound healing, anti-bacterial and/or anti-inflammatory agents
11/14/2002	US20020168763 Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
11/14/2002	US20020168740 Kinase for use in the treatment of inflammation, viral infection, cancer, sepsis, psoriasis and restenosis
11/14/2002	US20020168728 Generation preferential proteins; obtain gram-negative prokaryotic cell, transform with nucleotide sequences coding protein, culture, recover protein
11/14/2002	US20020168726 Bacterial antigens and vaccine compositions
11/14/2002	US20020168716 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of tumors, immunological, autoimmune, skin, viral, bone, nervous system and inflammatory disorders
11/14/2002	US20020168712 Molecules designated LDCAM
11/14/2002	US20020168673 Mitofusins, Fzo homologs and functional derivatives thereof
11/14/2002	US20020168633 Nucleotide fragment of the 23s rna of the genus chlamydia, use as a probe, primer, and in a reagent and a detection procedure
11/14/2002	US20020168631 Random gene unidirectional antisense library
11/14/2002	US20020168426 Viricides, bactericides
11/14/2002	US20020168411 Spill resistant pharmaceutical system
11/14/2002	US20020168392 Antimicrobial proteins
11/14/2002	US20020168384 Vaccine for poultry respiratory disorders

1 ... 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 ... 1798